Effect of PF-00734200 in Subjects With Type 2 Diabetes

Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 As Oral Monotherapy To Treat Adults With Type 2 Diabetes Mellitus

NCT02175121 ·Status: COMPLETED ·Phase: PHASE2

A Study Of PF-05190457 In Healthy Volunteers And Type-2 Diabetic Patients

NCT01372163 ·Status: TERMINATED ·Phase: PHASE1

A Phase 1 Single/Multiple Dose Study Of PF-06293620 To Assess Safety, Tolerability And Pharmacokinetics In Subjects With Type 2 Diabetes Mellitus

NCT02211261 ·Status: COMPLETED ·Phase: PHASE1

A Study of PF-05175157 in Healthy Volunteers and Type 2 Diabetic Patients

NCT01396161 ·Status: COMPLETED ·Phase: PHASE1

A 6-Week Study Of PF-05175157 In Type 2 Diabetes Mellitus

NCT01792635 ·Status: TERMINATED ·Phase: PHASE2

PF-06291874 Multiple Ascending Dose Study In Type 2 Diabetes Mellitus Patients

NCT01856595 ·Status: COMPLETED ·Phase: PHASE1

Study of Multiple Oral Doses of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus

NCT05158244 ·Status: COMPLETED ·Phase: PHASE1

Safety and Tolerability of Ascending Intravenous Doses of PF-05231023 In Adult Subjects With Type 2 Diabetes

NCT01396187 ·Status: COMPLETED ·Phase: PHASE1

Study Evaluating PPM-204 In Subjects With Type 2 Diabetes

NCT00425919 ·Status: TERMINATED ·Phase: PHASE2

Single Dose Escalation Study of PF-05190457 in Healthy Volunteers

NCT01247896 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Alone or in Combination With Sulfonylurea

NCT03770728 ·Status: TERMINATED ·Phase: PHASE3

A Clinical Trial to Study the Efficacy, Safety, Tolerability and Pharmacokinetics of P2202 in Patients of Type 2 Diabetes

NCT01674348 ·Status: TERMINATED ·Phase: PHASE2

Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy

NCT01240759 ·Status: COMPLETED ·Phase: PHASE2

A Trial To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Single Doses Of PF-04937319 In Subjects With Type 2 Diabetes Mellitus

NCT01044537 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate Safety, Efficacy of PBI-4050 & Its Effect on Relevant Biomarkers in T2DM Patients With Metabolic Syndrome

NCT03081598 ·Status: TERMINATED ·Phase: PHASE2

Glycaemic Control of Monthly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes

NCT02081118 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes

NCT01646320 ·Status: COMPLETED ·Phase: PHASE3

Safety And Tolerability Of Escalating Intravenous Doses Of PF-05231023 In Adult Subjects With Type 2 Diabetes

NCT01285518 ·Status: COMPLETED ·Phase: PHASE1

The Efficacy and Safety of PAZ320 on PPG and Insulin Blood Levels in Type II Diabetic Patients

NCT04569214 ·Status: WITHDRAWN ·Phase: PHASE2

A 2-week Trial Of PF-04991532 In Patients With Type 2 Diabetes

NCT01469065 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06882961 in Japanese Adults With Type 2 Diabetes Mellitus

NCT04552470 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of PF-06882961 in Chinese Adults With Type 2 Diabetes Mellitus

NCT04889157 ·Status: COMPLETED ·Phase: PHASE1

A Study of RO6811135 in Patients With Type 2 Diabetes Who Are Inadequately Controlled With Metformin

NCT01951183 ·Status: WITHDRAWN ·Phase: PHASE2

Multiple Dose Study of PF-04991532 in Patients With Type 2 Diabetes

NCT01129258 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)

NCT00110851 ·Status: COMPLETED ·Phase: PHASE2